Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$501M |
| 2 |
AbbVie
ABBV
|
+$381M |
| 3 |
Eli Lilly
LLY
|
+$377M |
| 4 |
Adobe
ADBE
|
+$368M |
| 5 |
Qualcomm
QCOM
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.38B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.03B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$589M |
| 4 |
Tesla
TSLA
|
+$536M |
| 5 |
Stellantis
STLA
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.88% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Financials | 10.3% |
| 5 | Industrials | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PetMed Express
PETS
$42.5M
| $56K | ﹤0.01% |
3,602
+2,868
| +391% | +$54K |
|
1752
Fulgent Genetics
FLGT
$559M
| $55.5K | ﹤0.01% |
1,798
| – | – |
|
|
MIO
1753
DELISTED
Pioneer Municipal High Income Opportunities Fund
MIO
| $55.5K | ﹤0.01% |
5,000
| – | – |
|
|
WSR
1754
DELISTED
Whitestone REIT
WSR
| $55.1K | ﹤0.01% |
+6,318
| New | +$61.1K |
|
|
GAP
1755
The Gap Inc
GAP
$6.84B
| $54.2K | ﹤0.01% |
5,852
| – | – |
|
1756
Invesco Mortgage Capital
IVR
$776M
| $53.6K | ﹤0.01% |
+4,811
| New | +$62K |
|
|
PINC
1757
DELISTED
Premier
PINC
| $53.6K | ﹤0.01% |
1,656
+213
| +15% | +$6.97K |
|
1758
Marcus Corp
MCS
$732M
| $53.5K | ﹤0.01% |
+3,320
| New | +$51K |
|
1759
RE/MAX Holdings
RMAX
$200M
| $52.6K | ﹤0.01% |
2,802
+579
| +26% | +$11.5K |
|
1760
Crinetics Pharmaceuticals
CRNX
$8.86B
| $52.6K | ﹤0.01% |
3,295
| – | – |
|
1761
Vanda Pharmaceuticals
VNDA
$312M
| $52K | ﹤0.01% |
+7,701
| New | +$54.1K |
|
1762
Immunovant
IMVT
$8.09B
| $51.9K | ﹤0.01% |
3,616
| – | – |
|
|
CMRC
1763
Commerce.com Inc Series 1
CMRC
$224M
| $51.3K | ﹤0.01% |
6,198
| – | – |
|
1764
DMC Global
BOOM
$121M
| $50.8K | ﹤0.01% |
+2,525
| New | +$57.8K |
|
1765
AngioDynamics
ANGO
$562M
| $50.7K | ﹤0.01% |
+5,322
| New | +$68.1K |
|
1766
Liquidity Services
LQDT
$1.17B
| $50.4K | ﹤0.01% |
+3,907
| New | +$53.1K |
|
1767
Urban Outfitters
URBN
$5.99B
| $50K | ﹤0.01% |
1,873
| – | – |
|
1768
Powell Industries
POWL
$8.46B
| $49.3K | ﹤0.01% |
+3,768
| New | +$52.2K |
|
|
BIG
1769
DELISTED
Big Lots, Inc.
BIG
| $49.2K | ﹤0.01% |
4,555
+3,939
| +639% | +$59.6K |
|
1770
Kymera Therapeutics
KYMR
$9.1B
| $49K | ﹤0.01% |
1,642
| – | – |
|
1771
Herbalife
HLF
$1.23B
| $48K | ﹤0.01% |
3,036
| – | – |
|
1772
Twist Bioscience
TWST
$5.62B
| $47.5K | ﹤0.01% |
3,550
| – | – |
|
1773
The RMR Group
RMR
$342M
| $47.4K | ﹤0.01% |
1,810
+247
| +16% | +$6.92K |
|
1774
PubMatic
PUBM
$581M
| $46.5K | ﹤0.01% |
3,425
| – | – |
|
1775
California Resources
CRC
$4.75B
| $46.2K | ﹤0.01% |
1,199
-336
| -22% | -$13.9K |
|
Similar funds
Amundi's Q1 2023 Portfolio in Review
As of Q1 2023, Amundi held 2,154 positions worth $186B, up 1.8% from $182B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Amundi's Q1 2023 filing shows 278 new, 828 increased, 617 reduced and 102 closed positions. Its largest new stake was GE HealthCare: 514,041 shares worth $41.7M. The largest sale was Linde, an estimated $1.38B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q1 2023 buy was GE HealthCare: 514,041 shares worth $41.7M.
- Amundi added most to Intel in Q1 2023, an estimated $501M increase.
- Amundi's biggest Q1 2023 reduction was Linde, cutting an estimated $1.38B.
- Amundi fully exited SVB Financial Group in Q1 2023, selling an estimated $59.9M.
- Amundi's ten largest holdings make up 20% of its $186B portfolio in Q1 2023.
- Amundi opened 278 new positions and closed 102 in Q1 2023.
- Amundi's portfolio value rose 1.8% quarter-over-quarter to $186B.
Based on Amundi's 13F filing for Q1 2023, filed 15 May 2023.